Skip to main content
Log in

Prognostischer Wert einer perkutanen Koronarintervention bei Patienten mit stabiler Angina pectoris

Schlussfolgerungen einer Metaanalyse von 17 randomisierten Studien unter Einschluss von COURAGE

Prognostic value of a percutaneous coronary intervention in patients with stable angina pectoris

Conclusions from a meta-analysis of 17 randomized studies including COURAGE

  • Interventionelle Kardiologie
  • Published:
Der Kardiologe Aims and scope

Zusammenfassung

Die Behandlung der stabilen Angina pectoris umfasst medikamentöse wie revaskularisierende Maßnahmen. Eine Revaskularisation kann mittels perkutaner Koronarintervention (PCI) oder Bypassoperation erfolgen. Bei allen Therapiemaßnahmen wird sowohl eine Behandlung der Beschwerden als auch eine Verbesserung der Prognose angestrebt. Während die Effektivität einer PCI zur Behandlung der Beschwerden unbestritten ist, wurde die Effektivität einer PCI zur Verbesserung der Prognose der Patienten kontrovers diskutiert. Allerdings war keine der bisher randomisiert durchgeführten Einzelstudien aufgrund der fehlenden „Power“ geeignet, den Effekt einer PCI auf das Überleben der Patienten mit stabiler Angina pectoris zu evaluieren. Die hier vorgestellte Metaanalyse fasst nun alle randomisiert durchgeführten Studien zusammen und berechnet die Effektivität einer PCI auf das Langzeitüberleben der Patienten im Vergleich zur medikamentösen Therapie. Dabei konnte gezeigt werden, dass bei einer mittleren Beobachtungsdauer von 51 Monaten in allen Studien zusammengenommen die Gesamtsterblichkeit im Vergleich zur rein medikamentösen Therapie signifikant um 20% gesenkt werden konnte.

Abstract

Treatment options for patients with stable coronary artery disease are based on medical drugs and revascularization procedures. Revascularization in patients with coronary artery disease can be performed by bypass surgery or percutaneous coronary intervention (PCI). The aim of both medical drugs and revascularization procedures is to relieve symptoms and to improve survival. While the impact of PCI on the reduction of symptoms in patients with stable angina pectoris is well established, its effects on the prognosis of these patients are still not defined. None of the randomized studies performed in comparison to medical treatment alone was able to assess the effect of a PCI on mortality. We therefore performed a meta-analysis of 17 randomized trials comparing a PCI-based invasive strategy with medical treatment alone for all-cause death. After an average follow-up period of 51 months in these trials, patients with a PCI-based invasive strategy had a 20% significant reduction in all-cause mortality compared to medical treatment alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Abrams J (2005) Clinical practice. Chronic stable angina. N Engl J Med 352: 2524–2533

    Article  PubMed  CAS  Google Scholar 

  2. Bavry A, Kumbhani D, Rassi A et al. (2006) Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 48: 1319–1325

    Article  PubMed  Google Scholar 

  3. Bech G, De Bruyne B, Pijls N et al. (2001) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103: 2928–2934

    PubMed  CAS  Google Scholar 

  4. Boden W, O’rourke R, Teo K et al. (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356: 1503–1516

    Article  PubMed  CAS  Google Scholar 

  5. Bruckenberger E (2007) Herzbericht 2006

  6. Bundesgeschäftsstelle für Qualitätssicherung (2007) Koronarangiographie und PCI

  7. Dakik H, Kleiman N, Farmer J et al. (1998) Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 98: 2017–2023

    PubMed  CAS  Google Scholar 

  8. Davies R, Goldberg A, Forman S et al. (1997) Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 95: 2037–2043

    PubMed  CAS  Google Scholar 

  9. Erne P, Schoenenberger A, Burckhardt D et al. (2007) Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. Jama 297: 1985–1991

    Article  PubMed  CAS  Google Scholar 

  10. Folland E, Hartigan P, Parisi A (1997) Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a veterans affairs cooperative randomized trial. Veterans affairs ACME investigatorS. J Am Coll Cardiol 29: 1505–1511

    Article  PubMed  CAS  Google Scholar 

  11. Freemantle N, Cleland J, Young P et al. (1999) Beta blockade after myocardial infarction: systematic review and meta regression analysis. Bmj 318: 1730–1737

    PubMed  CAS  Google Scholar 

  12. Hambrecht R, Walther C, Mobius-Winkler S et al. (2004) Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 109: 1371–1378

    Article  PubMed  Google Scholar 

  13. Henderson R, Pocock S, Clayton T et al. (2003) Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 42: 1161–1170

    Article  PubMed  Google Scholar 

  14. Higgins J, Thompson S, Deeks J et al. (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557–560

    Article  PubMed  Google Scholar 

  15. Hueb W, Soares P, Almeida De Oliveira S et al. (1999) Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 100: II107–II113

    PubMed  CAS  Google Scholar 

  16. Keeley E, Boura J, Grines Cl (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361: 13–20

    Article  PubMed  Google Scholar 

  17. Madsen J, Nielsen T, Grande P et al. (2007) Revascularization compared to medical treatment in patients with silent vs. symptomatic residual ischemia after thrombolyzed myocardial infarction – the DANAMI study. Cardiology 108: 243–251

    Article  PubMed  Google Scholar 

  18. Mahmarian J, Dakik H, Filipchuk N et al. (2006) An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 48: 2458–2467

    Article  PubMed  Google Scholar 

  19. Parisi A, Folland E, Hartigan P (1992) A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med 326: 10–16

    PubMed  CAS  Google Scholar 

  20. Pfisterer M, Buser P, Osswald S et al. (2003) Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. Jama 289: 1117–1123

    Article  PubMed  Google Scholar 

  21. Pitt B, Waters D, Brown W et al. (1999) Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Engl J Med 341: 70–76

    Article  PubMed  CAS  Google Scholar 

  22. Rita-2 Studiengruppe (1997) Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet 350: 461–468

    Google Scholar 

  23. Schomig A, Mehilli J, De Waha A et al. (2008) A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 52: 894–904

    Article  PubMed  Google Scholar 

  24. Sievers N, Hamm C, Herzner A et al. (1993) Medical therapy versus PTCA: a prospective, randomized trial in patients with asymptomatic coronary single-vessel disease. Circulation 88 (Suppl I): I-297 (Abstract)

    Google Scholar 

  25. Soares P, Hueb Wa, Lemos P et al. (2006) Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Circulation 114: I420–424

    Article  PubMed  Google Scholar 

  26. Statistisches Bundesamt (2008) Tabelle Todesursachen. http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Content/Statistiken/Gesundheit/Todesursachen/Tabellen/Content75/SterbefaelleInsgesamt,templateId=renderPrint.psml

  27. Timmis A, Feder G, Hemingway H (2007) Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution. Heart 93: 786–791

    Article  PubMed  Google Scholar 

  28. Weintraub W, Spertus J, Kolm P et al. (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359: 677–687

    Article  PubMed  CAS  Google Scholar 

  29. Wilt T, Bloomfield H, Macdonald R et al. (2004) Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 164: 1427–1436

    Article  PubMed  CAS  Google Scholar 

  30. Zeymer U, Uebis R, Vogt A et al. (2003) Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation 108: 1324–1328

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Herr Prof. Seyfarth gibt an, Vortragshonorare der Firmen Bristol-Myers Squibb, Lilly, Sanofi-Aventis erhalten zu haben. Herr Prof. Kastrati gibt an, Vortragshonorare der Firmen Bristol-Myers Squibb, Cordis, GlaxoSmithKline, Lilly, Medtronic, Novartis, Sanofi-Aventis erhalten zu haben. Herr Prof. Schömig gibt an, finanzielle Forschungsmittel der folgenden Institutionen und Firmen erhalten zu haben: TU München, Bayerische Forschungsstiftung, Amersham/General Electric, Bristol-Myers Squibb, Cordis, Cryocath, Guidant, Medtronic, Nycomed, Schering.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Seyfarth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seyfarth, M., de Waha, A., Mehilli, J. et al. Prognostischer Wert einer perkutanen Koronarintervention bei Patienten mit stabiler Angina pectoris. Kardiologe 2, 479–487 (2008). https://doi.org/10.1007/s12181-008-0129-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-008-0129-2

Schlüsselwörter

Keywords

Navigation